Ziprasidone-associated mania: A review and report of 2 additional cases

Clinical Neuropharmacology

Volumn 28, Issue 2, 2005, Pages 83-86

  Keating, Anne M ^a   Aoun, Suzanne L ^a,b   Dean, Charles E ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Atypical antidepressant; Mania; Side effect; Ziprasidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; FLUPHENAZINE DECANOATE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LORAZEPAM; OLANZAPINE; OMEPRAZOLE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; TIOTIXENE; TRAZODONE; ZIPRASIDONE; ZOLPIDEM;

ADULT; AGGRESSIVENESS; AKATHISIA; ANAMNESIS; ANOREXIA; AUDITORY HALLUCINATION; AWARENESS; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG POTENCY; HOSPITALIZATION; HUMAN; INSOMNIA; IRRITABILITY; LOGORRHEA; MALE; MANIA; NORADRENALIN UPTAKE; ONSET AGE; PARANOIA; PRESCRIPTION; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SEROTONIN UPTAKE; SIDE EFFECT; TARDIVE DYSKINESIA; TREMOR;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; SCHIZOPHRENIA; THIAZOLES;

EID: 16344390346     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000159952.64640.28     Document Type: Review

References (21)

1. Keck PE Jr, Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry. 2003;160:741-748.
2. Keck PE Jr, Reeves KR, Harrigan EP. Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies. J Clin Psychopharmacol. 2001;21:27-35.
3. Caley CF, Cooper CK. Ziprasidone: the fifth atypical antipsychotic. Ann Pharmacother. 2002;36:839-851.
4. Davis R, Risch SC. Ziprasidone induction of hypomania in depression? Am J Psychiatry. 2002;159:673-674.
5. 2a in mood changes induced by atypical antipsychotics. J Clin Psychiatry. 2002;63:1185-1186.
6. Baldassano CF, Ballas C, Datto SM, et al. Ziprasidone-associated mania: a case series and review of the mechanism. Bipolar Disord. 2003;5:72-75.
7. Nolan BP, Schulte JJ Jr. Mania associated with initiation of ziprasidone. J Clin Psychiatry. 2003;64:336.
8. Larson MF, Hauser A. Possible ziprasidone-induced mania. J Am Acad Child Adolesc Psychiatry. 2003;42:1012-1013.
9. Privitera MR, Maharaj K. Mania from dose-related ziprasidone augmentation of an SSRI. J Clin Psychiatry. 2003;64:1393-1394.
10. Brieger P. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course. J Clin Psychiatry. 2004;65:132.
11. Keck PE Jr, McElroy SL. Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology, 3rd ed. Washington, DC: American Psychiatric Publishing, 2004, pp 865-883.
12. Seeger TF, Seymour PA, Schmidt AW, et al. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther. 1995;275:101-113.
13. Schmidt AW, Lebel LA, Howard HR Jr, et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol. 2001;425:197-201.
14. Tatsumi M, Jansen K, Blakely RD, et al. Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol. 1999;368:277-283.
15. Rachid F, Bertschy G, Bondolfi G, et al. Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. J Clin Psychiatry. 2004;65:1537-1545.
16. Haddad P. Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry. 1997;58(Suppl 7):17-21.
17. Szabo ST, Gould T, Manji HK. Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders. In: Schatzberg AF, Nemeroff CB, eds. American Psychiatric Publishing Textbook of Psychopharmacology, 3rd ed. Washington DC: American Psychiatric Publishing, 2004, pp 3-52.
18. Butler MO, Morinobu S, Duman RS. Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex. J Neurochem. 1993;61:1270-1276.
19. 2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry. 2004;55:225-233.
20. Lesch KP. Variation in serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs. Eur Neuropsychopharmacol. 2001;11:457-474.
21. Duman RS. The neurochemistry of depressive disorders: preclinical studies. In: Charney DS, Nestler EJ, eds. Neurobiology of Mental Illness, 2nd ed. Oxford: Oxford University Press, 2004, pp 421-439.